{"title": "Allergy Therapeutics vacuna contra alergias latinas", "author": "Equipo de Redacci\u00f3n", "url": "https://www.pharmabiz.net/la-compania-experta-en-vacunas-para-la-alergia-esta-enfocada-en-avanzar-con-su-negocio-en-los-mercados-emergentes-de-america-latina/", "hostname": "pharmabiz.net", "description": "(Bilingual Version) La compa\u00f1\u00eda, experta en vacunas para la alergia, est\u00e1 enfocada en avanzar con su negocio en los mercados emergentes de Am\u00e9rica Latina. http://www.allergytherapeutics.com/Allergy-Therapeutics-enters-Latin-America.aspx As\u00ed la empresa confirm\u00f3 que sus primeros mercados de inter\u00e9s ser\u00e1n Argentina, Colombia, Venezuela y Chile. Esta expansi\u00f3n ser\u00e1 realizada sin dudas, a trav\u00e9s de la amplia plataforma de los...", "sitename": "PharmaBiz.NET", "date": "2011-08-30", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "La compa\u00f1\u00eda, experta en vacunas para la alergia, est\u00e1 enfocada en avanzar con su negocio en los mercados emergentes de Am\u00e9rica Latina.\n[http://www.allergytherapeutics.com/Allergy-Therapeutics-enters-Latin-America.aspx](http://www.allergytherapeutics.com/Allergy-Therapeutics-enters-Latin-America.aspx)\nAs\u00ed la empresa confirm\u00f3 que sus primeros mercados de inter\u00e9s ser\u00e1n Argentina, Colombia, Venezuela y Chile.\nEsta expansi\u00f3n ser\u00e1 realizada sin dudas, a trav\u00e9s de la amplia plataforma de los chilenos de Recalcine, quienes entraron en Allergy Therapeutics con una participaci\u00f3n del 40 por ciento durante 2010.\n[http://www.alejandroweinstein.com/noticias/es/recalcine-compra-el-40-de-laboratorio-allergy-therapeutics.html](http://www.alejandroweinstein.com/noticias/es/recalcine-compra-el-40-de-laboratorio-allergy-therapeutics.html)\nEl lanzamiento oficial en Argentina fue en el marco del Congreso Argentino de Alergia que se celebr\u00f3 en Buenos Aires en agosto pasado.\nY aunque todav\u00eda le falta el OK final de la ANMAT para sus productos, sus caballitos de batalla ya est\u00e1n alistados para salir al mercado.\nSer\u00e1n Tyrovac (Tyrosin), una vacuna subcut\u00e1nea para prevenir alergias de \u00e1caros, p\u00f3lenes y gram\u00edneas. Y tambi\u00e9n Acarogen (Oralvac), una vacuna sublingual para prevenir alergias de \u00e1caros.\nLa empresa se apoyar\u00e1 por ahora en la estructura de Fada Pharma para poder realizar la importaci\u00f3n de sus productos.\nEn Am\u00e9rica Latina la rinitis al\u00e9rgica tiene una prevalencia del 7 por ciento. Las alergias m\u00e1s usuales son causadas por \u00e1caros, epitelios de animales, p\u00f3lenes y cucarachas.\nLas estimaciones de la compa\u00f1\u00eda indican que los gastos en medicinas de los mercados emergentes se duplicar\u00edan entre 2010 y 2015 para alcanzar u$s300,000 millones de acuerdo a IMS.\nSuperar\u00edan as\u00ed a los mercados de Alemania, Francia, Italia, Espa\u00f1a y Reino Unido combinados, y se acercar\u00edan a los niveles de EE.UU.\n_____________________________________________________________________________________________\nEnglish Version\nTuesday 30th, August 2011\nThe company, specializing in allergy vaccines, is set to expand its business into the emerging markets of Latin America.\n[http://www.allergytherapeutics.com/Allergy-Therapeutics-enters-Latin-America.aspx](http://www.allergytherapeutics.com/Allergy-Therapeutics-enters-Latin-America.aspx)\nInitially, Allergy Therapeutics has confirmed that its main areas of interest will be in Argentina, Colombia, Venezuela and Chile.\nThere is no doubt that the expansion of the business will take place through the platform provided by Recalcine of Chile, who entered Allergy Therapeutics with a participation of 40% in 2010.\n[http://www.alejandroweinstein.com/noticias/es/recalcine-compra-el-40-de-laboratorio-allergy-therapeutics.html](http://www.alejandroweinstein.com/noticias/es/recalcine-compra-el-40-de-laboratorio-allergy-therapeutics.html)\nThe official launch in Argentina took place in Buenos Aires last August in the Argentine Allergy Congress.\nEven though the products still need to receive a final go-ahead from ANMAT, Allergy Therapeutics\u00b4 bread and butter will be Tyrovac (Tyrosin) and Acarogen (Oralvac). Tyrovac is a subcutaneous vaccine used to prevent mite, pollen and grass allergies, and Acarogen is a sublingual vaccine used to prevent mite allergies.\nFor the time being the company will lean on the structure provided by Fada Pharma in order to import its products.\nIn Latin America 7% of people suffer from allergic rhinitis, and the most common allergies are caused by mites, pollen, cockroaches and animals.\nThe company estimates that spending on medicines in Emerging Markets will double between 2010 and 2015 to around $300 billion according to IMS.\nThis way they would overtake Germany, France, Italy, Spain and the UK combined, and approach US spending levels.", "language": null, "image": "https://www.pharmabiz.net/wp-content/uploads/2011/08/AllergyTherapeutics.jpg", "pagetype": "article", "links": ["https://www.facebook.com/pharmabizweb/?ref=hl", "https://www.instagram.com/pharmabiz/", "https://www.linkedin.com/company/3122224/admin/", "https://twitter.com/pharmabizweb", "#", "https://www.pharmabiz.net/categoria/ejecutivos/", "https://www.pharmabiz.net/categoria/empresas/", "https://www.pharmabiz.net/categoria/informes/", "https://www.pharmabiz.net/categoria/latinoamerica/", "https://www.pharmabiz.net/categoria/regulaciones/", "https://www.pharmabiz.net/categoria/licitaciones-publicas/", "#", "https://www.pharmabiz.net/categoria/agenda/", "https://www.pharmabiz.net/categoria/canal-hospitalario/", "https://www.pharmabiz.net/categoria/otc/", "https://www.pharmabiz.net/categoria/coyuntura/", "https://www.pharmabiz.net/categoria/resultados-financieros/", "https://www.pharmabiz.net/categoria/resumen-semanal/", "https://www.pharmabiz.net/categoria/retail/", "https://www.pharmabiz.net/categoria/salud-animal/", "https://www.pharmabiz.net/suscripcion/", "https://www.pharmabiz.net/categoria/english-versions/", "#", "#", "#", "#", "#", "https://www.pharmabiz.net/about/", "https://www.pharmabiz.net/evolucion/", "https://www.pharmabiz.net/staff/", "https://www.pharmabiz.net/micros-radiales/", "https://www.pharmabiz.net/pharmabiz-en-los-medios/", "https://www.pharmabiz.net/categoria/versao-em-portugues/", "#", "#", "http://www.ares-enderiz.com/", "https://www.audifarmsalud.com/", "#", "https://www.pharmabiz.net/", "https://www.pharmabiz.net/", "https://www.pharmabiz.net/categoria/ejecutivos/", "https://www.pharmabiz.net/categoria/empresas/", "https://www.pharmabiz.net/categoria/informes/", "https://www.pharmabiz.net/categoria/latinoamerica/", "https://www.pharmabiz.net/categoria/regulaciones/", "https://www.pharmabiz.net/categoria/licitaciones-publicas/", "#", "https://www.pharmabiz.net/categoria/agenda/", "https://www.pharmabiz.net/categoria/canal-hospitalario/", "https://www.pharmabiz.net/categoria/otc/", "https://www.pharmabiz.net/categoria/coyuntura/", "https://www.pharmabiz.net/categoria/resultados-financieros/", "https://www.pharmabiz.net/categoria/resumen-semanal/", "https://www.pharmabiz.net/categoria/retail/", "https://www.pharmabiz.net/categoria/salud-animal/", "https://www.pharmabiz.net/suscripcion/", "https://www.pharmabiz.net/categoria/english-versions/", "https://www.facebook.com/pharmabizweb/?ref=hl", "https://www.instagram.com/pharmabiz/", "https://www.linkedin.com/company/3122224/admin/", "https://twitter.com/pharmabizweb", "#", "#", "https://www.pharmabiz.net/", "https://www.pharmabiz.net/categoria/empresas/", "https://www.pharmabiz.net/categoria/empresas/", "https://www.pharmabiz.net/categoria/newsletter/", "https://www.pharmabiz.net/author/team-pharmabiz/", "#", "#english", "http://www.allergytherapeutics.com/Allergy-Therapeutics-enters-Latin-America.aspx", "http://www.alejandroweinstein.com/noticias/es/recalcine-compra-el-40-de-laboratorio-allergy-therapeutics.html", "http://www.allergytherapeutics.com/Allergy-Therapeutics-enters-Latin-America.aspx", "http://www.alejandroweinstein.com/noticias/es/recalcine-compra-el-40-de-laboratorio-allergy-therapeutics.html", "https://www.facebook.com/sharer.php?u=https%3A%2F%2Fwww.pharmabiz.net%2Fla-compania-experta-en-vacunas-para-la-alergia-esta-enfocada-en-avanzar-con-su-negocio-en-los-mercados-emergentes-de-america-latina%2F", "https://twitter.com/intent/tweet?text=Allergy+Therapeutics+vacuna+contra+alergias+latinas&url=https%3A%2F%2Fwww.pharmabiz.net%2Fla-compania-experta-en-vacunas-para-la-alergia-esta-enfocada-en-avanzar-con-su-negocio-en-los-mercados-emergentes-de-america-latina%2F&via=PharmaBiz.NET", "https://pinterest.com/pin/create/button/?url=https://www.pharmabiz.net/la-compania-experta-en-vacunas-para-la-alergia-esta-enfocada-en-avanzar-con-su-negocio-en-los-mercados-emergentes-de-america-latina/&media=https://www.pharmabiz.net/wp-content/uploads/2011/08/AllergyTherapeutics.jpg&description=Allergy+Therapeutics+vacuna+contra+alergias+latinas", "whatsapp://send?text=Allergy+Therapeutics+vacuna+contra+alergias+latinas %0A%0A https://www.pharmabiz.net/la-compania-experta-en-vacunas-para-la-alergia-esta-enfocada-en-avanzar-con-su-negocio-en-los-mercados-emergentes-de-america-latina/", "https://www.linkedin.com/shareArticle?mini=true&url=https://www.pharmabiz.net/la-compania-experta-en-vacunas-para-la-alergia-esta-enfocada-en-avanzar-con-su-negocio-en-los-mercados-emergentes-de-america-latina/&title=Allergy+Therapeutics+vacuna+contra+alergias+latinas", "mailto:?subject=Allergy Therapeutics vacuna contra alergias latinas&body=https://www.pharmabiz.net/la-compania-experta-en-vacunas-para-la-alergia-esta-enfocada-en-avanzar-con-su-negocio-en-los-mercados-emergentes-de-america-latina/", "#", "https://www.pharmabiz.net/abbott-northia-medix-estrena-y-mas/", "https://www.pharmabiz.net/pfizer-bye-bye-lipitor/", "https://www.pharmabiz.net/author/team-pharmabiz/", "https://www.pharmabiz.net/author/team-pharmabiz/", "#", "#", "https://www.pharmabiz.net/sidus-le-vende-apasmo-a-gramon/", "https://www.pharmabiz.net/categoria/empresas/", "https://www.pharmabiz.net/sidus-le-vende-apasmo-a-gramon/", "https://www.pharmabiz.net/schneider-electric-tableros-de-transferencia-para-mision-critica/", "https://www.pharmabiz.net/categoria/manufactura-y-tecnica/", "https://www.pharmabiz.net/schneider-electric-tableros-de-transferencia-para-mision-critica/", "https://www.pharmabiz.net/duena-de-ayudin-blanco-de-un-ciberataque/", "https://www.pharmabiz.net/categoria/empresas/", "https://www.pharmabiz.net/duena-de-ayudin-blanco-de-un-ciberataque/", "https://www.pharmabiz.net/schott-pharma-busca-hasta-e-987m-en-ipo/", "https://www.pharmabiz.net/categoria/empresas/", "https://www.pharmabiz.net/schott-pharma-busca-hasta-e-987m-en-ipo/", "https://www.pharmabiz.net/pases-el-tercer-informe-de-septiembre/", "https://www.pharmabiz.net/categoria/ejecutivos/", "https://www.pharmabiz.net/pases-el-tercer-informe-de-septiembre/", "https://www.pharmabiz.net/cosmetica-nuevo-up-grade-salarial/", "https://www.pharmabiz.net/categoria/paritarias/", "https://www.pharmabiz.net/cosmetica-nuevo-up-grade-salarial/", "#", "#", "https://www.pharmabiz.net/biogen-arrancaron-los-recortes-y-mas/", "https://www.pharmabiz.net/categoria/informes/", "https://www.pharmabiz.net/biogen-arrancaron-los-recortes-y-mas/", "https://www.pharmabiz.net/author/cris-kroll/", "https://www.pharmabiz.net/sandoz-sale-de-argentina-tras-acuerdo-con-biosidus/", "https://www.pharmabiz.net/categoria/informes/", "https://www.pharmabiz.net/sandoz-sale-de-argentina-tras-acuerdo-con-biosidus/", "https://www.pharmabiz.net/author/cristinalaura/", "https://www.pharmabiz.net/servier-desvincula-apms-y-tambalea-filial-local/", "https://www.pharmabiz.net/categoria/empresas/", "https://www.pharmabiz.net/servier-desvincula-apms-y-tambalea-filial-local/", "https://www.pharmabiz.net/author/cris-kroll/", "https://www.pharmabiz.net/pharmabiz-llega-a-los-15-anos-en-este-2022/", "https://www.pharmabiz.net/categoria/15-aniversario-%f0%9f%8e%88/", "https://www.pharmabiz.net/pharmabiz-llega-a-los-15-anos-en-este-2022/", "https://www.pharmabiz.net/author/cris-kroll/", "https://www.pharmabiz.net/osde-sigue-el-desgrane-de-profesionales/", "https://www.pharmabiz.net/categoria/informes/", "https://www.pharmabiz.net/osde-sigue-el-desgrane-de-profesionales/", "https://www.pharmabiz.net/author/florencia-lippo/", "https://www.pharmabiz.net/sobreseimiento-penal-para-pharmabiz/", "https://www.pharmabiz.net/categoria/informes/", "https://www.pharmabiz.net/sobreseimiento-penal-para-pharmabiz/", "https://www.pharmabiz.net/author/team-pharmabiz/", "https://www.pharmabiz.net/", "mailto:info@pharmabiz.net", "https://www.facebook.com/pharmabizweb/?ref=hl", "https://www.instagram.com/pharmabiz/", "https://www.linkedin.com/company/3122224/admin/", "https://twitter.com/pharmabizweb"]}